Skip to main content
. 2014 Jan 24;8:7. doi: 10.3389/fncel.2014.00007

Figure 6.

Figure 6

Comparison of microglial (Iba-1 labeled) immunoreactivity in SOD1G93A, SCI and sciatic nerve injured mice. (A) Representative confocal images of the ventral part of the lumbar spinal cord of wild type/naïve, SOD1G93A at 8, 12, and 16 weeks of age, SCI and sciatic nerve crush injured animals. Scale bar 10 μm. (B) Iba-1 immunoreactivity quantification revealed a progressive increase of microglial reactivity during disease progression in SOD1G93A mice. At late stages (16 weeks of age), Iba-1 immunoreactivity level is similar to that observed in SCI and sciatic nerve injured animals. Values are mean ± s.e.m. *p < 0.05, **p < 0.01, ***p < 0.001 vs. respective wild type/naïve animals.